The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study

Launched by UMC UTRECHT · Aug 28, 2019

Keywords

ClinConnect Summary

The MOMENTUM Study is a research trial that looks at a new type of radiation therapy using advanced technology called the MR-Linac. This study aims to find out how well this treatment works for various types of cancer, including breast, prostate, and lung cancers, and how it affects patients' quality of life. Researchers hope that by using this technology, they can improve cancer control and help patients live longer and better lives.

To participate in the study, you need to be at least 18 years old and either be scheduled for or have already received treatment using the MR-Linac system. You’ll also need to give your written consent to join the study. However, if you have certain health conditions that prevent you from having an MRI, such as pregnancy or certain metal implants, you may not be eligible. If you participate, you can expect to contribute to important research that could benefit future cancer patients while receiving care with this innovative technology.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patient is to undergo or has completed imaging or treatment procedures on an MR-Linac;
• • Patient provides written, informed consent;
• • Patient is 18 years old or older.
• Exclusion Criteria:
• • MRI exclusion criteria, including
• • MRI contraindications as per usual clinical care, such as (possible) pregnancy; claustrophobia and metal or electronic implants not compatible with MRI.